These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 11968060
1. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. Hostettler ME, Knapp PE, Carlson SL. Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060 [Abstract] [Full Text] [Related]
5. [Effect of platelet activating factor receptor at spinal cord neurocyte membrane on secondary damage after spinal cord injury]. Xiao J, Zhao D, Jia L. Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):120-3. PubMed ID: 8758444 [Abstract] [Full Text] [Related]
6. Functional PAF receptors in glia cells: binding parameters and regulation of expression. Brodie C. Int J Dev Neurosci; 1994 Nov; 12(7):631-40. PubMed ID: 7900545 [Abstract] [Full Text] [Related]
8. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Lenoir M, Pedruzzi E, Rais S, Drieu K, Perianin A. Biochem Pharmacol; 2002 Apr 01; 63(7):1241-9. PubMed ID: 11960600 [Abstract] [Full Text] [Related]
9. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P. Br J Pharmacol; 1991 Dec 01; 104(4):797-804. PubMed ID: 1667286 [Abstract] [Full Text] [Related]
15. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE. J Lipid Mediat; 1993 Aug 01; 8(1):31-51. PubMed ID: 8257776 [Abstract] [Full Text] [Related]
16. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. Lee LW, Peng HC, Ko WC, Hung WC, Su CH, Lin CH, Huang TF, Yen MH, Sheu JR. Eur J Pharmacol; 1999 Jan 08; 364(2-3):239-46. PubMed ID: 9932729 [Abstract] [Full Text] [Related]
17. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure. Lopes-Martins R, Catelli M, Araújo C, Estato V, Cordeiro R, Tibiriçá E. Eur J Pharmacol; 1996 Jul 25; 308(3):287-94. PubMed ID: 8858301 [Abstract] [Full Text] [Related]
18. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. Kecskeméti V, Balogh I. J Physiol Pharmacol; 2000 Dec 25; 51(4 Pt 1):723-35. PubMed ID: 11192945 [Abstract] [Full Text] [Related]
19. Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils. Renesto P, Vicart P, Paulin D, Chignard M. Br J Pharmacol; 1996 Mar 25; 117(5):902-6. PubMed ID: 8851508 [Abstract] [Full Text] [Related]
20. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils. Koike H, Imanishi N, Natsume Y, Morooka S. Eur J Pharmacol; 1994 Nov 15; 269(3):299-309. PubMed ID: 7895770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]